Y 
19.65
-0.30%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥39.61bn
FY2017FY2025
Net income
CN¥719.5m
FY2017FY2025
Free cash flow
CN¥29.6m
FY2017FY2025
Shareholders' equity
−CN¥13.23bn
FY2017FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥39.61bn | CN¥5.63bn | CN¥5.39bn | CN¥5.01bn | CN¥4.02bn | CN¥3.17bn | CN¥1.30bn | CN¥731.6m | CN¥455.7m |
| Research and development | CN¥3.45bn | CN¥540.0m | CN¥743.4m | CN¥803.8m | CN¥607.4m | CN¥424.6m | CN¥275.4m | CN¥184.0m | CN¥133.1m |
| Operating income | CN¥1.53bn | CN¥154.3m | −CN¥483.5m | −CN¥693.2m | −CN¥906.6m | −CN¥1.81bn | −CN¥600.9m | −CN¥219.1m | −CN¥130.0m |
| Net income | CN¥719.5m | CN¥82.2m | −CN¥549.9m | −CN¥727.0m | −CN¥995.7m | −CN¥1.75bn | −CN¥601.5m | −CN¥208.9m | −CN¥133.6m |
| Diluted earnings per share | 5.98 | 0.69 | -4.57 | -5.85 | -8.08 | -15.45 | -5.69 | -2.11 | -1.11 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥13.24bn | CN¥1.81bn | CN¥1.67bn | CN¥2.28bn | CN¥2.63bn | CN¥2.07bn | CN¥2.09bn | CN¥619.6m | CN¥161.9m |
| Cash and short-term investments | CN¥4.95bn | CN¥655.8m | CN¥526.7m | CN¥1.02bn | CN¥826.9m | CN¥1.19bn | CN¥1.62bn | CN¥435.4m | CN¥40.1m |
| Total liabilities | CN¥26.20bn | CN¥3.90bn | CN¥3.80bn | CN¥3.75bn | CN¥3.36bn | CN¥3.48bn | CN¥1.79bn | CN¥1.76bn | CN¥1.12bn |
| Debt | CN¥12.37bn | CN¥1.85bn | CN¥1.60bn | CN¥1.48bn | CN¥1.25bn | CN¥987.7m | CN¥899.2m | CN¥878.0m | CN¥878.0m |
| Shareholders' equity | −CN¥13.23bn | −CN¥2.14bn | −CN¥2.19bn | −CN¥1.54bn | −CN¥807.1m | −CN¥1.41bn | CN¥300.1m | −CN¥1.14bn | −CN¥714.9m |
| Shares outstanding | 120m | 119m | 120m | 124m | 123m | 113m | 106m | 99m | 121m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | CN¥55.2m | −CN¥67.9m | −CN¥438.1m | −CN¥603.1m | −CN¥1.35bn | −CN¥321.6m | −CN¥372.3m | −CN¥100.3m | −CN¥87.1m |
| Capital spending | −CN¥25.6m | −CN¥11.8m | −CN¥17.9m | −CN¥69.8m | −CN¥64.1m | −CN¥36.9m | −CN¥18.2m | −CN¥14.0m | −CN¥10.7m |
| Free cash flow | CN¥29.6m | −CN¥79.7m | −CN¥456.0m | −CN¥672.9m | −CN¥1.41bn | −CN¥358.4m | −CN¥390.4m | −CN¥114.3m | −CN¥97.8m |
Financial ratios
Data as of 9 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Operating margin | 3.0% | 2.7% | -8.7% | -13.6% | -22.1% | -57.0% |
| Net margin | 1.8% | 1.5% | -10.2% | -14.5% | -24.8% | -55.4% |
| Return on equity | -5.4% | -3.8% | 25.1% | 47.4% | 123.4% | 124.5% |
| Return on assets | 5.4% | 4.5% | -33.0% | -31.9% | -37.8% | -84.7% |
| Free cash flow yield | 4.1% | -2.9% | -21.4% | -26.3% | -63.8% | -15.4% |
| Revenue growth | 5.0% | 4.4% | 7.5% | 24.8% | 26.8% | 142.7% |
| Earnings growth | 30.6% | -114.9% | -24.4% | -27.0% | -43.2% | 191.5% |
| Current ratio | 0.59x | 0.50x | 0.42x | 0.59x | 0.75x | 0.55x |
| Debt to equity | -0.93x | -0.85x | -0.71x | -0.94x | -1.46x | -0.64x |
| Equity ratio | -100.0% | -117.9% | -131.2% | -67.4% | -30.6% | -68.0% |
| Interest coverage | 2.88x | 2.08x | -6.76x | -14.66x | -28.42x | -57.85x |
| R&D as a share of sales | 8.7% | 9.6% | 13.8% | 16.0% | 15.1% | 13.4% |
| Buybacks as a share of market value | -1.3% | 1.4% | 3.2% | -0.9% | -8.5% | -7.4% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 98.4% | 65.2% | — |
Valuation history
At each fiscal year end
| FY2025 | |
|---|---|
| Price to earnings | 11.8 |
| Price to sales | 0.2 |
Market value over time
31 Oct 2019 to 8 Oct 2026, in CNY
CN¥1.38bnCN¥1.97bn
Share price return
Finished calendar years
| 2025 | |
|---|---|
| Return | 21% |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.